StockNews.com Upgrades ResMed (NYSE:RMD) to “Buy”
ResMed (NYSE:RMD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. Several other research firms also recently weighed in on RMD. The Goldman Sachs Group initiated coverage on shares of ResMed in a report […]
ResMed (NYSE:RMD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. Several other research firms also recently weighed in on RMD. The Goldman Sachs Group initiated coverage on shares of ResMed in a report […]
